Technology area: Medical Devices & Mechanical Engineering
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready • 1 patents granted in the last 365 days
Olympus Terumo Biomaterials Corp. currently manages 1 pending office action. This activity is focused in the Medical Devices & Mechanical Engineering technology area. With 1 pending office action, the company's current patent prosecution efforts are concentrated on a specific matter rather than a broad array of simultaneous filings.
The examination is conducted by 1 distinct examiner who operates within 1 distinct art unit. KAMIKAWA, TRACY L is the busiest examiner for this portfolio and is responsible for 1 pending office action. This 1 to 1 relationship between the examiner and the pending action centralizes the technical review within the Medical Devices & Mechanical Engineering sector.
The reliance on 1 distinct examiner within 1 distinct art unit means that the prosecution strategy is highly dependent on the specific interpretations of KAMIKAWA, TRACY L. For a company in the Medical Devices & Mechanical Engineering field, this 1 pending office action requires a focused response to the specific requirements of the assigned official. The lack of multiple distinct examiners simplifies the administrative tracking of the portfolio but increases the impact of the decisions made by KAMIKAWA, TRACY L.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| KAMIKAWA, TRACY L | 1 | 58.2% | +37.1% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17880836 | IMPLANT | KAMIKAWA, TRACY L | 54d |
| Art Unit | Apps |
|---|---|
| 3775 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 17880836 | IMPLANT | KAMIKAWA, TRACY L | 3775 | §103 | Final Rejection | 54d | Pending | Aug 04, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialOlympus Terumo Biomaterials Corp. has 1 pending office actions as of October 2026, spread across 1 art units and 1 examiners.
Tracy L Kamikawa has the most, with 1 of Olympus Terumo Biomaterials Corp.'s pending office actions.
Mostly Medical Devices & Mechanical Engineering (USPTO Tech Center 3700), based on where its pending office actions are examined.
